Discover 2,221 paid clinical trials in Hayward, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,221
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
for
Breast Cancer, Triple Negative Breast Cancer, Residual Cancer,
Location: San Francisco CA, Nashville TN, Philadelphia PA,
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT04434040
Phase 2, Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
for
Pancreatic Neoplasm
Location: San Francisco CA, Sacramento CA, Burbank CA,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 50 - 70+
Code: NCT04239573
Recruiting
Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)
for
Middle Schools, School Exclusion, School Community,
Location: Capitola CA, Yuba City CA, Salem OR
Sponsor: University of Oregon
Sex: All
Age: 8 - 15
Code: NCT06292078
Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: San Francisco CA, Vallejo CA, Sacramento CA,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
A Study of Tarlatamab for People With Prostate Cancer
for
Metastatic Prostate Cancer
Location: San Francisco CA, San Diego CA, Philadelphia PA,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Male
Age: 18+
Code: NCT07111507
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
for
Castration-Resistant Prostatic Cancer, Metastasis
Location: San Francisco CA, Los Angeles CA, Orange CA, Seattle WA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06863272
Phase 1, Phase 2, Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
for
Diffuse Midline Glioma, H3 K27-Altered,
Location: San Francisco CA, Los Angeles CA, Orange CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 21
Code: NCT04870944
Phase 1, Phase 2, Recruiting
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
for
ALK-positive NSCLC, ALK-Positive Lung Cancer,
Location: San Francisco CA, West Valley City UT, Aurora CO,
Sponsor: TRIANA Biomedicines, Inc.
Sex: All
Age: 18+
Code: NCT07491497
Phase 1, Phase 2, Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
for
Preterm Delivery, Obstetrical Complications
Location: San Francisco CA, Salt Lake City UT, Houston TX,
Sponsor: The George Washington University Biostatistics Center
Sex: Female
Age: 14+
Code: NCT06980025
Phase 3, Recruiting
Intraoperative Use of ClearEdge Device in Breast Conserving Surgery
for
Breast Cancer
Location: San Francisco CA
Sponsor: LS BioPath
Sex: Female
Age: 18+
Code: NCT05456373
Recruiting
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
for
Metastatic Digestive System Neuroendocrine Tumor G1,
Location: San Francisco CA, Salt Lake City UT, Phoenix AZ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05773274
Phase 2, Recruiting
Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
for
Low-grade Glioma, Recurrent Low Grade Glioma,
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 2 - 25
Code: NCT07506239
Recruiting
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
for
Complex Regional Pain Syndrome Type I
Location: Napa CA, Reno NV, Santa Monica CA, Pasadena CA,
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
for
Lupus Nephritis (LN)
Location: San Francisco CA, Rochester MN, Houston TX
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 60
Code: NCT06975787
Phase 1, Recruiting
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
for
Advanced Lung Neuroendocrine Tumor,
Location: San Francisco CA, Los Angeles CA, Beverly Hills CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04665739
Phase 2, Recruiting
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
for
Lung Cancer (Diagnosis)
Location: Palo Alto CA, Grand Junction CO, San Antonio TX,